--- name: Lindus Health slug: lindus-health site: cro website_domain: lindushealth.com summary: Lindus Health is a clinical research organization delivering end-to-end trial execution across Phase 1–2a programs with proprietary AI-driven patient recruitment, integrated site networks, and performance-based pricing. The company has completed 45+ trials with 82% on-time enrollment and operates across the US, UK, and Europe. Headquartered in Boston, United States. tagline: Technology-enabled CRO delivering faster, higher-quality clinical trials through AI-powered patient recruitment and integrated trial operations. founded_year: employee_count_band: 51-200 employee_count_label: 51–200 parent_name: parent_slug: hq_country: US tier2_domain_verified: false updated_at: 2026-08-19T00:00:41.716Z services_count: 6 modalities_count: 1 indications_count: 4 locations_count: 3 review_signal_gate: closed generated_by: BioBM Editorial AI --- # Lindus Health Technology-enabled CRO delivering faster, higher-quality clinical trials through AI-powered patient recruitment and integrated trial operations. Listed on cro.directory. ## Summary Lindus Health is a clinical research organization delivering end-to-end trial execution across Phase 1–2a programs with proprietary AI-driven patient recruitment, integrated site networks, and performance-based pricing. The company has completed 45+ trials with 82% on-time enrollment and operates across the US, UK, and Europe. Headquartered in Boston, United States. ## At a glance - Employees (est.): 51–200 - HQ country: US ## Services - Phase I Clinical Trials - Phase II Clinical Trials - Clinical Operations - Data Management & eClinical - Regulatory Affairs - Medical Writing ## Modalities - Small Molecule ## Indications - Metabolic - Psychiatry - Cardiovascular - Respiratory ## Locations - Headquarters, Boston, Massachusetts, United States - Office, UK, United Kingdom - Office, Europe ## Long description ## Overview Lindus Health is a technology-enabled clinical research organization (CRO) that positions itself as an "anti-CRO" by combining vertically integrated trial operations with proprietary software and AI-powered patient recruitment. The company specializes in accelerating clinical trial timelines through end-to-end study execution, from protocol design through data management and regulatory submission. ## Core Capabilities **Trial Execution & Operations** - Completed 45+ clinical trials across diverse therapeutic areas (metabolic health, CNS, cardiovascular, rare disease) - Proven track record: 82% of Lindus-managed trials complete enrollment on or ahead of schedule - Average 72.9% faster enrollment compared to industry baseline - Global execution spanning US, UK, and Europe with integrated APAC partnerships - Phase 1–2a focus; in-licenses clinical-stage assets and develops them internally **Patient Recruitment & Retention** - Proprietary omni-channel recruitment leveraging access to 40+ million electronic medical records (EMRs) in primary care - AI-powered EHR screening and patient pre-screening with advanced algorithms - Central Patient Recruitment Coordinator (PRC) team managing virtual patient interactions - Geo-targeted digital advertising, primary care network relationships, and patient advocacy partnerships - Lindus Virtual Site for fully remote assessments; Lindus Site Network for local engagement; External Site integration for sponsor flexibility - Fierce CRO Award winner for Outstanding Patient Recruitment and Retention **Technology Platform** - Proprietary eClinical platform (Citrus™) for centralized screening, enrollment pathway management, and real-time site capacity metrics - AI agents for pre-screening, patient question answering, visit scheduling, and participant triage - Real-time data access and live funnel metrics across entire patient journey - Clinical data management (CDM) software integration with EHR systems and advanced analytics **Regulatory & Compliance** - Clinical trial application preparation and regulatory submission support - Risk-shared, fixed-price, and milestone-based payment models - Aligned incentives through performance-based pricing ## Therapeutic Areas & Indications Proven execution in metabolic health (type 2 diabetes, obesity), CNS (major depressive disorder), cardiovascular (hypertension), respiratory (asthma), and chronic conditions (chronic fatigue syndrome). Non-ultrarare chronic disease focus aligned with core operational capabilities. ## Funding & Scale - $80+ million total funding from investors including Balderton, Peter Thiel, Creandum, Firstminute Capital, and Seedcamp - 120-person team across US and Europe - Founded as technology-first CRO; expanded into asset development and in-licensing ## Differentiation Lindus Health eliminates traditional CRO handoffs by combining in-house trial design, execution, and patient recruitment under one integrated team and technology stack. The company targets faster timelines, higher enrollment quality, and adaptive trial designs not practical with standard biopharma partners. ## Related companies - [PharPoint Research](/companies/pharpoint) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/lindus-health/pharpoint) - [ProRelix Research](/companies/prorelixresearch) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/lindus-health/prorelixresearch) - [ClinActis Pte Ltd](/companies/clinactis) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/clinactis/lindus-health) - [JSS Medical Research](/companies/jssresearch) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/jssresearch/lindus-health) - [Velocity Clinical Research](/companies/velocityclinical) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/lindus-health/velocityclinical) - [Linical](/companies/linical) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/lindus-health/linical) - [TFS HealthScience](/companies/tfscro) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/lindus-health/tfscro) - [YPrime](/companies/yprime) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/lindus-health/yprime) _Profile last updated: 2026-08-19T00:00:41.716Z. Profile facts may include AI-assisted enrichment._ Auto-generated by BioBM Editorial AI for machine-readable profile access.